Drug Side Effects

EGFR GENE MUTATION

This adverse event was reported 364 times

These drugs are most commonly taken by patients reporting EGFR GENE MUTATION:

# Drug Count
0 OSIMERTINIB 147
1 GEFITINIB 128
2 AFATINIB 87
3 ERLOTINIB HYDROCHLORIDE 67
4 ERLOTINIB 56
5 CARBOPLATIN 51
6 PEMETREXED DISODIUM 48
7 PEMETREXED 43
8 BEVACIZUMAB 28
9 GEMCITABINE HYDROCHLORIDE 23
See all common drugs associated with EGFR GENE MUTATION

EGFR GENE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GEFITINIB 128 0.0144
1 AFATINIB 87 0.0133
2 ERLOTINIB HYDROCHLORIDE 67 0.0054
3 OSIMERTINIB 147 0.0050
4 NECITUMUMAB 1 0.0022
5 VINORELBINE 11 0.0016
6 DACOMITINIB 1 0.0014
7 PEMETREXED DISODIUM 48 0.0013
8 SELPERCATINIB 1 0.0008
9 PRALSETINIB 1 0.0006
See all drugs enriched for association with EGFR GENE MUTATION

These drug classes are most commonly taken by patients reporting EGFR GENE MUTATION:

# Drug class Count
0 Kinase Inhibitor [EPC] 311
1 Platinum-based Drug [EPC] 67
2 Folate Analog Metabolic Inhibitor [EPC] 46
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 28
4 Microtubule Inhibitor [EPC] 27
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 26
6 Corticosteroid [EPC] 11
7 RANK Ligand Inhibitor [EPC] 9
8 Topoisomerase Inhibitor [EPC] 8
9 Aromatase Inhibitor [EPC] 6
See all common drug classes associated with EGFR GENE MUTATION

EGFR GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Kinase Inhibitor [EPC] 311 0.0006
1 Platinum-based Drug [EPC] 67 0.0003
2 Progestin Antagonist [EPC] 1 0.0002
3 Microtubule Inhibitor [EPC] 27 0.0002
4 Programmed Death Ligand-1 Blocker [EPC] 4 0.0002
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 28 0.0002
6 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 3 0.0002
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 26 0.0001
8 Topoisomerase Inhibitor [EPC] 8 0.0001
9 Folate Analog Metabolic Inhibitor [EPC] 46 0.0001
See all drug classes enriched for association with EGFR GENE MUTATION